Augurix confirms its commitment to quality

13 Jun 2016

Augurix Diagnostic SA  is proud to announce the achievement of ISO 9001 and  ISO 13485 re-certification for our Quality Management System, demonstrating our commitment to the quality of our IVD products.

Our process controls, documentation, and quality standards meet or exceed all ISO 9001 and ISO 13485 requirements. Certification is a proof of quality and our customers can expect a constant and high level of reliability and transparency.


Simtomax® at the UEG Week in Vienna

30 Oct 2014

The 22nd United European Gastroenterology week (UEGW) took place last week in Vienna, with 13’000 participants. Many different topics were covered in more than170 sessions, conferences, workshops or presentations. Simtomax® was particularly put in evidence in four poster sessions, a private conference and in the exhibition.

Abstracts and Poster presentations

Four abstracts were accepted for presentation, outlining the most recent conclusions drawn in various clinical studies with Simtomax®

  • Point Of Care Testing For Adult Coeliac Disease: A Potential Role In Endoscopy, a study by Prof David Sanders at the Royal Hallamshire Hospital in Sheffield, (UK), investigating the potential use of point-of-care tests for Celiac Disease in pre-endoscopy
  • Comparison Of Three Commercially Available Point Of Care Tests For Coeliac Disease, a study by Dr Peter Mooney at Royal Hallamshire Hospital in Sheffield, (UK)
  • Assessing Adherence To Gluten Free Diet In Coeliac Disease: Can We Avoid Duodenal Biopsy?, another study by the same group at Royal Hallamshire Hospital in Sheffield, (UK)
  • Efficacy Of Deamidated Gliadin Peptide-Based Point-Of-Care Test (Simtomax) For The Early
Diagnosis Of Coeliac Disease In Paediatric Patients, a study by Dr Isabel Polanco from Chidren ́s University Hospital La Paz in Madrid (Spain)

Simtomax® conference

Prof David Sanders presented the clinical data from his study performed on over 500 patients at the Royal Hallamshire Hospital in Sheffield, (UK), suggesting the potential use of Simtomax® in pre-endoscopy.

« Simtomax could be used to appropriately identify patients requiring a duodenal biopsy within the endoscopic setting. »

Dr Michela Schaeppi, from the Pediatric Gastroenterology Unit, Geneva University (Switzerland) presented the clinical study performed on 112 patients.

Simtomax® in the exhibition

Simtomax was present on the booth of our commercial partner Tillotts Pharma, where several visitors stopped by.

Снимок экрана 2014-10-30 в 12.15.58


Simtomax® launched in Australia!

30 Oct 2014

Simtomax®, our rapid test for the early screening of celiac disease, was launched by our partner Healthscreen Services in Australia, through the leading pharmacy chains Amcal and AmcalMax. Pharmacists perform the test as part of a screening service, and refer the patients to their doctors if required. A dedicated questionnaire is used to engage the patients and assess their suitability for being tested. The story has been relayed in the national press and media.